logo

For the Inventor, By the Inventor

Tokyo, Japan

Shinichiro Ashida

This inventor holds 7 USPTO granted patents. Top assignees: Daiichi Seiyaku Co., Ltd., Daiichi Pharmaceutical Co., Ltd., Santen Pharmaceutical Co., Ltd.. Active years: 1981-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinichiro Ashida. Retrieved from https://idiyas.com/inventor/shinichiro-ashida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 35(Granted Patents)


Location History:

  • Minamifunabori, JP (1981)
  • Tokyo, JP (1986 - 1993)

Company Filing History:

goldMedal5 out of 70 
 
Daiichi Seiyaku Co., Ltd.
 patents
silverMedal2 out of 200 
 
Daiichi Pharmaceutical Co., Ltd.
 patents
bronzeMedal1 out of 282 
 
Santen Pharmaceutical Co., Ltd.
 patents
where one patent can have more than one assignee

Years Active: 1981-1993

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5182276 - Nootropic agent (1993-01-26),
2. 5166169 - Treating agent for peripheral circulatory disturbances (1992-11-24),
3. 4942171 - The compound, 6-(1-imidazolyl (1990-07-17),
4. 4933349 - Treating agent for heart failure (1990-06-12),
5. 4746668 - Method for treating retinopathy (1988-05-24),
6. 4596806 - 7-piperidino-1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-one having (1986-06-24),
7. 4284773 - 1,2,3,5-Tetrahydroimidazothienopyrimidin-2-ones (1981-08-18),

Title: Shinichiro Ashida: Innovator in Nootropic Agents

Introduction

Shinichiro Ashida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nootropic agents. With a total of 7 patents to his name, Ashida's work has garnered attention for its innovative approaches to treating various health conditions.

Latest Patents

One of Ashida's latest patents focuses on a nootropic agent designed to treat peripheral circulatory disturbances. This invention includes a compound represented by a specific formula, wherein R can be an imidazolyl group, a thiazolyl group, or a pyridyl group. The parameters n and m are defined to enhance the effectiveness of the treatment, making it a valuable addition to the pharmaceutical landscape.

Career Highlights

Throughout his career, Shinichiro Ashida has worked with notable companies such as Daiichi Seiyaku Co., Ltd. and Daiichi Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Ashida has collaborated with esteemed colleagues, including Kyoko Sakuma and Fumiyoshi Ishikawa. These partnerships have played a crucial role in advancing his research and expanding the impact of his inventions.

Conclusion

Shinichiro Ashida's innovative work in the field of nootropic agents highlights his dedication to improving health outcomes. His contributions continue to influence the pharmaceutical industry and inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…